All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database

Diabetes Care

Volumn 36, Issue 8, 2013, Pages 2366-2371

  Taylor, Kathryn S ^a,b   Heneghan, Carl J ^a,b   Farmer, Andrew J ^a,b   Fuller, Alice M ^a,b   Adler, Amanda I ^c   Aronson, Jeffrey K ^a,b   Stevens, Richard J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b University of Manchester   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTOR; SEX DIFFERENCE; SMOKING; UNITED KINGDOM; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; EPIDEMIOLOGY; FACTUAL DATABASE; MORTALITY; RISK;

ADULT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; RISK; SEX FACTORS;

EID: 84886059217     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1513     Document Type: Article

References (37)

1. Tunstall-PedoeH,Kuulasmaa K,MähönenM, Tolonen H, Ruokokoski E Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353:1547-1557
2. Mortality trends [Internet], 2012. Available from http://www.mortality- trends.org. Accessed 11 July 2012
3. Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation 2008;117:598-604
4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713
5. Spencer EA, Pirie KL, Stevens RJ, et al.; Million Women Study Collaborators. Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study. Eur J Epidemiol 2008;23:793-799
6. Colhoun HM, Betteridge DJ, Durrington PN, et al.; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative AtorvastatinDiabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-696
7. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011;378:815-825
8. NICE clinical guideline 87. Type 2 diabetes. The management of Type 2 diabetes [article online], 2010. Available from http://guidence.nice.ord.uk/ CG87. Accessed 11 July 2012
9. SIGN clinical guideline 116. The management of diabetes [article online], 2010. Available from http://www.sign.ac.uk/guidlines/fulltext/116/index.html. Accessed 11 July 2012
10. Quality and outcomes framework 2011/12. Delivering investment in general practice. British Medical Association. April 2011.
11. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265:627-631
12. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturityonset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151:1141-1147
13. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA. Mortality in people with type 2 diabetes in the UK.DiabetMed 2006; 23:516-521
14. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495-2499
15. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007;147:149-155
16. Barengo NC, Katoh S, Moltchanov V, Tajima N, Tuomilehto J. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J 2008;29:1889-1895
17. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 2008;337:a236
18. Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007;115:1544-1550
19. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012;35:1252-1257
20. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K; Steering Group of the National Diabetes Register. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008;51:2187-2196
21. Gulliford MC, Charlton J. Is relative mortality of type 2 diabetes mellitus decreasing? Am J Epidemiol 2009;169:455-461
22. Barnett KN, Ogston SA, McMurdo MET, Morris AD, Evans JM. A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with type 2 diabetes in Tayside, Scotland. Diabet Med 2010;27:1124-1129
23. NHS Information Centre. National Diabetes Audit Mortality Analysis 2007-2008. Leeds, NHS Information Center, 2011
24. Royal College of General Practitioners and NHS Diabetes. Coding, classification and diagnosis of diabetes [article online], 2011. Available from www.diabetes.nhs.uk/our-work-areas/classification-of-diabetes. Accessed 11 July 2012
25. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990;36: 15-19
26. Collett D. Modelling Survival Data in Medical Research. 2nd ed. Boca Raton, FL, Chapman and Hall/CRC, 2003
27. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452
28. Categories for blood pressure levels in adults: your guide to lowering high blood pressure [Internet]. Available from http://www.nhlbi.nih.gov/hbp/ detect/categ.htm. Accessed 11 July 2012
29. GP practice notebook: reference range cholesterol [Internet]. Available from http:///www.gpnotebook.co.uk. Accessed 11 July 2012
30. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14
31. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999;21:299-304
32. Little RJA, Rubin DB. Statistical Analysis With Missing Data. 2nd ed. New York, John Wiley and Sons, 2002
33. Van Staa T-D, Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994;3:15-21
34. Walker JJ, Livingstone SJ, Colhoun HM, et al.; Scottish Diabetes Research Network Epidemiology Group. Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care 2011; 34:1127-1132
35. Charlton J, Latinovic R, Gulliford MC. Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study. Diabetes Care 2008;31:1761-1766
36. Evans JMM, Barnett KN, Ogston SA, Morris AD. Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality? Diabetologia 2007;50:729-732
37. Ringborg A, Lindgren P, Martinell M, Yin DD, Schön S, Stålhammar J. Prevalence and incidence of type 2 diabetes and its complications 1996-2003 destimates from a Swedish population-based study. Diabet Med 2008;25:1178-1186